Sterling Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-50,090
| Closed | -$6.56M | – | 947 |
|
|
2019
Q2 | $6.56M | Buy |
+50,090
| New | +$6.56M | 0.06% | 223 |
|
|
2018
Q4 | – | Sell |
-32,797
| Closed | -$4.56M | – | 954 |
|
|
2018
Q3 | $4.56M | Buy |
32,797
+6,933
| +27% | +$964K | 0.04% | 253 |
|
|
2018
Q2 | $3.21M | Buy |
25,864
+2,982
| +13% | +$370K | 0.03% | 303 |
|
|
2018
Q1 | $2.55M | Buy |
22,882
+10,009
| +78% | +$1.12M | 0.02% | 353 |
|
|
2017
Q4 | $1.54M | Buy |
12,873
+10,697
| +492% | +$1.28M | 0.01% | 473 |
|
|
2017
Q3 | $306K | Buy |
+2,176
| New | +$306K | ﹤0.01% | 826 |
|
|
2017
Q1 | – | Sell |
-1,992
| Closed | -$244K | – | 1025 |
|
|
2016
Q4 | $244K | Buy |
+1,992
| New | +$244K | ﹤0.01% | 880 |
|
|
2016
Q2 | – | Sell |
-1,880
| Closed | -$261K | – | 1016 |
|
|
2016
Q1 | $261K | Buy |
+1,880
| New | +$261K | ﹤0.01% | 836 |
|
|
2015
Q1 | – | Sell |
-6,146
| Closed | -$1.14M | – | 981 |
|
|
2014
Q4 | $1.14M | Sell |
6,146
-10,541
| -63% | -$1.95M | 0.01% | 625 |
|
|
2014
Q3 | $2.77M | Sell |
16,687
-5,291
| -24% | -$877K | 0.03% | 277 |
|
|
2014
Q2 | $3.43M | Sell |
21,978
-7,070
| -24% | -$1.1M | 0.03% | 216 |
|
|
2014
Q1 | $4.42M | Sell |
29,048
-3,952
| -12% | -$601K | 0.04% | 185 |
|
|
2013
Q4 | $4.39M | Buy |
+33,000
| New | +$4.39M | 0.04% | 178 |
|